These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16087899)

  • 1. Hemostatic markers of recanalization in patients with ischemic stroke treated with rt-PA.
    Martí-Fàbregas J; Borrell M; Cocho D; Belvís R; Castellanos M; Montaner J; Pagonabarraga J; Aleu A; Molina-Porcel L; Díaz-Manera J; Bravo Y; Alvarez-Sabín J; Dávalos A; Fontcuberta J; Martí-Vilalta JL
    Neurology; 2005 Aug; 65(3):366-70. PubMed ID: 16087899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical deterioration after intravenous recombinant tissue plasminogen activator treatment: a multicenter transcranial Doppler study.
    Saqqur M; Molina CA; Salam A; Siddiqui M; Ribo M; Uchino K; Calleja S; Garami Z; Khan K; Akhtar N; O'Rourke F; Shuaib A; Demchuk AM; Alexandrov AV;
    Stroke; 2007 Jan; 38(1):69-74. PubMed ID: 17138949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment hemostatic markers of symptomatic intracerebral hemorrhage in patients treated with tissue plasminogen activator.
    Cocho D; Borrell M; Martí-Fàbregas J; Montaner J; Castellanos M; Bravo Y; Molina-Porcel L; Belvís R; Díaz-Manera JA; Martínez-Domeño A; Martínez-Lage M; Millán M; Fontcuberta J; Martí-Vilalta JL
    Stroke; 2006 Apr; 37(4):996-9. PubMed ID: 16497981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual flow at the site of intracranial occlusion on transcranial Doppler predicts response to intravenous thrombolysis: a multi-center study.
    Saqqur M; Tsivgoulis G; Molina CA; Demchuk AM; Shuaib A; Alexandrov AV;
    Cerebrovasc Dis; 2009; 27(1):5-12. PubMed ID: 19018132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of pretreatment blood pressure with tissue plasminogen activator-induced arterial recanalization in acute ischemic stroke.
    Tsivgoulis G; Saqqur M; Sharma VK; Lao AY; Hill MD; Alexandrov AV;
    Stroke; 2007 Mar; 38(3):961-6. PubMed ID: 17255548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous versus combined (intravenous and intra-arterial) thrombolysis in acute ischemic stroke: a transcranial color-coded duplex sonography--guided pilot study.
    Sekoranja L; Loulidi J; Yilmaz H; Lovblad K; Temperli P; Comelli M; Sztajzel RF
    Stroke; 2006 Jul; 37(7):1805-9. PubMed ID: 16763175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the benefit of early recanalization sustained at 3 months? A prospective cohort study.
    Labiche LA; Al-Senani F; Wojner AW; Grotta JC; Malkoff M; Alexandrov AV
    Stroke; 2003 Mar; 34(3):695-8. PubMed ID: 12624293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-thrombolysis haemostasis changes after rt-PA treatment in acute cerebral infarct. Correlations with cardioembolic aetiology and outcome.
    Sun X; Berthiller J; Derex L; Trouillas P; Diallo L; Hanss M
    J Neurol Sci; 2015 Feb; 349(1-2):77-83. PubMed ID: 25619569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial fibrillation as an independent predictor for no early recanalization after IV-t-PA in acute ischemic stroke.
    Kimura K; Iguchi Y; Yamashita S; Shibazaki K; Kobayashi K; Inoue T
    J Neurol Sci; 2008 Apr; 267(1-2):57-61. PubMed ID: 17964602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal profile of recanalization after intravenous tissue plasminogen activator: selecting patients for rescue reperfusion techniques.
    Ribo M; Alvarez-Sabín J; Montaner J; Romero F; Delgado P; Rubiera M; Delgado-Mederos R; Molina CA
    Stroke; 2006 Apr; 37(4):1000-4. PubMed ID: 16514102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early recanalization after intravenous administration of recombinant tissue plasminogen activator as assessed by pre- and post-thrombolytic angiography in acute ischemic stroke patients.
    Lee KY; Han SW; Kim SH; Nam HS; Ahn SW; Kim DJ; Seo SH; Kim DI; Heo JH
    Stroke; 2007 Jan; 38(1):192-3. PubMed ID: 17110611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with early recanalization failure following intravenous rt-PA therapy for ischemic stroke.
    Koga M; Arihiro S; Miyashita F; Yamamoto H; Yamada N; Nagatsuka K; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2013; 36(4):299-305. PubMed ID: 24135558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Change in hemostatic markers after recombinant tissue-type plasminogen activator is not associated with the chance of recanalization.
    Martí-Fàbregas J; Borrell M; Cocho D; Martínez-Ramírez S; Martínez-Corral M; Fontcuberta J; Martí-Vilalta JL
    Stroke; 2008 Jan; 39(1):234-6. PubMed ID: 18048863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recanalization after intravenous thrombolysis: does a recanalization time window exist?
    Wunderlich MT; Goertler M; Postert T; Schmitt E; Seidel G; Gahn G; Samii C; Stolz E; ;
    Neurology; 2007 Apr; 68(17):1364-8. PubMed ID: 17452580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The presence of a right-to-left shunt is associated with dramatic improvement after thrombolytic therapy in patients with acute ischemic stroke.
    Kimura K; Iguchi Y; Shibazaki K; Terasawa Y; Aoki J; Matsumoto N
    Stroke; 2009 Jan; 40(1):303-5. PubMed ID: 18845803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator.
    Molina CA; Alexandrov AV; Demchuk AM; Saqqur M; Uchino K; Alvarez-Sabín J;
    Stroke; 2004 Jan; 35(1):151-6. PubMed ID: 14671245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action.
    Bhatia R; Hill MD; Shobha N; Menon B; Bal S; Kochar P; Watson T; Goyal M; Demchuk AM
    Stroke; 2010 Oct; 41(10):2254-8. PubMed ID: 20829513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing of recanalization after tissue plasminogen activator therapy determined by transcranial doppler correlates with clinical recovery from ischemic stroke.
    Christou I; Alexandrov AV; Burgin WS; Wojner AW; Felberg RA; Malkoff M; Grotta JC
    Stroke; 2000 Aug; 31(8):1812-6. PubMed ID: 10926939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Combination of Clinical Features, Transcranial Doppler, and Alberta Stroke Program Early Computed Tomography Score (Computed Tomography Angiography) in Predicting Outcome in Intravenous Recombinant Tissue Plasminogen Activator-Treated Patients.
    Saqqur M; Ghrooda E; Ahmad A; Khan K; Hussain MS; Shuaib A
    J Stroke Cerebrovasc Dis; 2016 Aug; 25(8):2019-23. PubMed ID: 27241578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Admission fibrinolytic profile predicts clot lysis resistance in stroke patients treated with tissue plasminogen activator.
    Ribo M; Montaner J; Molina CA; Arenillas JF; Santamarina E; Alvarez-Sabín J
    Thromb Haemost; 2004 Jun; 91(6):1146-51. PubMed ID: 15175801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.